Form 8-K - Current report:
SEC Accession No. 0001467154-22-000108
Filing Date
2022-07-19
Accepted
2022-07-19 08:20:25
Documents
12
Period of Report
2022-07-13
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20220713.htm   iXBRL 8-K 46869
  Complete submission text file 0001467154-22-000108.txt   185100

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20220713.xsd EX-101.SCH 1893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20220713_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20220713_pre.xml EX-101.PRE 12502
6 EXTRACTED XBRL INSTANCE DOCUMENT novn-20220713_htm.xml XML 10815
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 221090437
SIC: 2834 Pharmaceutical Preparations